HLA antigens and immunoglobulin allotypes in patients with malignant melanoma

J. P. Pandey, A. H. Johnson, H. H. Fudenberg, D. B. Amos, J. U. Gutterman, E. M. Hersh

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

HLA antigens and Gm, A2m, and Km allotypes were examined in Caucasian patients with malignant melanoma. No significant associations were found for any of the HLA antigens tested. Significant association was found with Gm(2), and the relative risk for individuals with this marker was calculated at 1.9. The data indicate that Caucasians positive for Gm(2) are almost twice as likely to develop malignant melanoma as those without this marker.

Original languageEnglish (US)
Pages (from-to)185-190
Number of pages6
JournalHuman Immunology
Volume2
Issue number3
DOIs
StatePublished - May 1981

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'HLA antigens and immunoglobulin allotypes in patients with malignant melanoma'. Together they form a unique fingerprint.

  • Cite this

    Pandey, J. P., Johnson, A. H., Fudenberg, H. H., Amos, D. B., Gutterman, J. U., & Hersh, E. M. (1981). HLA antigens and immunoglobulin allotypes in patients with malignant melanoma. Human Immunology, 2(3), 185-190. https://doi.org/10.1016/0198-8859(81)90010-0